
|Articles|November 1, 2012
Merck Moves Forward with Plans for Vorapaxar Approval
Anticoagulation therapies reviewed, including Merck moving forward with FDA approval of vorapaxar despite bleeding risks
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
From Policy to Practice: Elevating Pharmacy’s Role in Quality and Patient Safety
2
Trump Executive Order Set to Reclassify Marijuana, Improve CBD Access
3
Trial Approvals Face Delays During COVID-19 Pandemic
4
Scripted for Her: HRT Black Box Removal
5

















































































































